| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Joseph V Moxon | Q56938686 |
| Jonathan Golledge | Q61192882 | ||
| P2093 | author name string | Smriti Murali Krishna | |
| P2860 | cites work | Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study. | Q45868651 |
| Relationship between HbA1c level and peripheral arterial disease | Q46618636 | ||
| Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study | Q46640201 | ||
| Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase | Q46927014 | ||
| The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure | Q46963168 | ||
| Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb | Q47225531 | ||
| Inflammation and oxidative stress are associated differently with endothelial function and arterial stiffness in healthy subjects and in patients with atherosclerosis | Q47981020 | ||
| Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs | Q47985997 | ||
| N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study | Q48195443 | ||
| Higher serum levels of soluble intracellular cell adhesion molecule-1 and soluble vascular cell adhesion molecule predict peripheral artery disease in haemodialysis patients | Q48624960 | ||
| Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects. | Q49203352 | ||
| Barriers to screening and diagnosis of peripheral artery disease by general practitioners | Q50146020 | ||
| Peripheral arterial disease detection, awareness, and treatment in primary care | Q28216456 | ||
| Thrombin and vascular inflammation | Q28246124 | ||
| NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease | Q28259845 | ||
| Vascular calcification: pathobiology of a multifaceted disease | Q28282418 | ||
| Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties | Q28300388 | ||
| Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training | Q30421761 | ||
| The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke | Q30676580 | ||
| Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis | Q30697267 | ||
| Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice | Q30711525 | ||
| Prevalence of nonatheromatous lesions in peripheral arterial disease. | Q50455772 | ||
| Impact of gradual blood flow increase on ischaemia-reperfusion injury in the rat cremaster microcirculation model. | Q50688000 | ||
| D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. | Q50753506 | ||
| Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study. | Q51170216 | ||
| A validated biomarker panel to identify peripheral artery disease. | Q51350033 | ||
| Correlation between ankle-brachial index, symptoms, and health-related quality of life in patients with peripheral vascular disease. | Q53348036 | ||
| Determinants of peripheral arterial disease in the elderly: the Rotterdam study. | Q54195793 | ||
| Waon therapy mobilizes CD34+ cells and improves peripheral arterial disease | Q54411307 | ||
| Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease. | Q54663191 | ||
| Critical limb ischemia. | Q55052558 | ||
| Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) | Q56287926 | ||
| The Role of Biomarkers and Genetics in Peripheral Arterial Disease | Q57413956 | ||
| Utility and barriers to performance of the ankle brachial index in primary care practice | Q57428616 | ||
| Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio | Q57767325 | ||
| Role of Matrix Metalloproteinases in Blood Flow–Induced Arterial Enlargement | Q58150276 | ||
| Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: Effect of an antioxidant treatment | Q58421092 | ||
| Acute Limb Ischemia | Q60142494 | ||
| Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration | Q60662462 | ||
| Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus | Q61831163 | ||
| Plasma myeloperoxidase level and peripheral arterial disease | Q61842056 | ||
| Basement Membrane Remodeling in Skeletal Muscles of Patients with Limb Ischemia Involves Regulation of Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinases | Q62796408 | ||
| The economics of femorocrural reconstruction for critical leg ischemia with and without autologous vein | Q67721613 | ||
| Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease | Q68186456 | ||
| Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. Results of a prospective randomized, double-blind, multicenter clinical trial | Q70383218 | ||
| Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia. | Q39918726 | ||
| Ethnic-specific prevalence of peripheral arterial disease in the United States | Q40230436 | ||
| Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus | Q40933115 | ||
| Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease | Q42181707 | ||
| Enhanced vascular endothelial growth factor gene expression in ischaemic skin of critical limb ischaemia patients | Q42554370 | ||
| Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy | Q43056383 | ||
| YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes. | Q43519963 | ||
| Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease | Q43614603 | ||
| C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study | Q43618417 | ||
| Living in a medically underserved county is an independent risk factor for major limb amputation | Q44067513 | ||
| Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication | Q44205508 | ||
| β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients | Q44285321 | ||
| Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. | Q44450748 | ||
| Serum paraoxonase-3 concentration is associated with insulin sensitivity in peripheral artery disease and with inflammation in coronary artery disease | Q44522315 | ||
| Endothelial progenitor cells in patients with severe peripheral arterial disease | Q44945223 | ||
| The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease. | Q45819487 | ||
| Role of NO in flow-induced remodeling of the rabbit common carotid artery | Q71656999 | ||
| Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage | Q71838405 | ||
| Hypoxic conditions decrease the mRNA expression of proalpha1(I) and (III) collagens and increase matrix metalloproteinases-1 of dermal fibroblasts in three-dimensional cultures | Q73154733 | ||
| Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease | Q73303024 | ||
| Secondary distal extension of infrainguinal bypass: long-term limb and patient survival | Q74320337 | ||
| Exercise training reduces the acute inflammatory response associated with claudication | Q78049895 | ||
| Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease | Q78171879 | ||
| Limb hemodynamics are not predictive of functional capacity in patients with PAD | Q79746097 | ||
| Mitochondrial defects and oxidative damage in patients with peripheral arterial disease | Q79823960 | ||
| Plasma NT-proBNP concentration is related to ambulatory pulse pressure in peripheral arterial disease | Q80410513 | ||
| A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences | Q80418532 | ||
| Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease | Q81269203 | ||
| Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia | Q82862777 | ||
| Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population | Q82878722 | ||
| Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal | Q82991530 | ||
| N-acetylcysteine attenuates leukocytic inflammation and microvascular perfusion failure in critically ischemic random pattern flaps | Q83935399 | ||
| Prognostic values of C-reactive protein levels on clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease | Q84575263 | ||
| VEGF: a surrogate marker for peripheral vascular disease | Q84847799 | ||
| Arterial tissue and plasma concentration of enzymatic-driven oxysterols are associated with severe peripheral atherosclerotic disease and systemic inflammatory activity | Q86166137 | ||
| Comparison of the serum lipidome in patients with abdominal aortic aneurysm and peripheral artery disease | Q87139589 | ||
| Gene therapy for peripheral arterial disease | Q87753368 | ||
| ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul | Q36426489 | ||
| Critical limb ischemia: cell and molecular therapies for limb salvage | Q36547498 | ||
| Correlation between plasma lipoprotein-associated phospholipase A2 and peripheral arterial disease | Q36900840 | ||
| The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction | Q37048102 | ||
| Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease | Q37097986 | ||
| Peripheral artery disease, biomarkers, and darapladib | Q37114477 | ||
| Niche regulation of muscle satellite cell self-renewal and differentiation | Q37121062 | ||
| The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type. | Q37129300 | ||
| Oxidation-specific biomarkers and risk of peripheral artery disease | Q37131142 | ||
| Circulating blood markers and functional impairment in peripheral arterial disease | Q37135754 | ||
| Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study | Q37212527 | ||
| Emerging hurdles in stem cell therapy for peripheral vascular disease | Q37246834 | ||
| Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease | Q37252119 | ||
| Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease | Q37361610 | ||
| Serum N-terminal pro-B-type natriuretic peptide levels are associated with functional capacity in patients with peripheral arterial disease | Q37373978 | ||
| Human studies of angiogenic gene therapy | Q37406656 | ||
| Matrix metalloproteinases and peripheral arterial disease | Q37559372 | ||
| Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature | Q37594251 | ||
| Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease | Q37604190 | ||
| Walking disability in patients with peripheral artery disease is associated with arterial endothelial function | Q37665969 | ||
| Treatment of peripheral arterial disease using stem and progenitor cell therapy. | Q37804562 | ||
| Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease | Q37818446 | ||
| Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis | Q37883007 | ||
| Arterial thrombus formation in cardiovascular disease | Q37897474 | ||
| Emerging biomarkers in heart failure | Q37956614 | ||
| Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success | Q38087578 | ||
| Nitric oxide and reactive oxygen species in limb vascular function: what is the effect of physical activity? | Q38130310 | ||
| Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: systematic review of revascularization in critical limb ischemia | Q38198199 | ||
| Thrombosis formation on atherosclerotic lesions and plaque rupture | Q38243253 | ||
| Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication | Q38338953 | ||
| The relevance of epigenetics to occlusive cerebral and peripheral arterial disease | Q38351869 | ||
| National health care costs of peripheral arterial disease in the Medicare population | Q38455005 | ||
| Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice | Q38532483 | ||
| Residual thrombin generation potential is inversely linked to the occurrence of atherothrombotic events in patients with peripheral arterial disease | Q39281529 | ||
| Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. | Q39593611 | ||
| Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study | Q33383115 | ||
| Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells | Q33450208 | ||
| Chronic critical limb ischemia: diagnosis, treatment and prognosis. | Q33597091 | ||
| Impaired vascular endothelial growth factor A and inflammation in patients with peripheral artery disease | Q33707341 | ||
| Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein. | Q33814653 | ||
| Gender and racial differences in endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease. | Q34288235 | ||
| Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis | Q34361910 | ||
| Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease | Q34374326 | ||
| Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial | Q34472601 | ||
| Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model | Q34515851 | ||
| Levels and values of lipoprotein-associated phospholipase A2, galectin-3, RhoA/ROCK, and endothelial progenitor cells in critical limb ischemia: pharmaco-therapeutic role of cilostazol and clopidogrel combination therapy. | Q34524341 | ||
| Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). | Q34586454 | ||
| An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease | Q34641120 | ||
| Arteriogenesis, a new concept of vascular adaptation in occlusive disease | Q34799047 | ||
| Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology | Q34998535 | ||
| Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis | Q35026202 | ||
| Association of lower extremity performance with cardiovascular and all-cause mortality in patients with peripheral artery disease: a systematic review and meta-analysis. | Q35026415 | ||
| Increased Serum N-Terminal Pro–B-Type Natriuretic Peptide Levels in Patients With Medial Arterial Calcification and Poorly Compressible Leg Arteries | Q35047848 | ||
| To screen or not to screen for peripheral arterial disease in subjects aged 80 and over in primary health care: a cross-sectional analysis from the BELFRAIL study | Q35063654 | ||
| Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology | Q35064459 | ||
| Temporal exposure of cryptic collagen epitopes within ischemic muscle during hindlimb reperfusion | Q35085422 | ||
| A biomarker panel for peripheral arterial disease | Q35098249 | ||
| The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008 | Q35565818 | ||
| Local control of skeletal muscle blood flow during exercise: influence of available oxygen | Q35601718 | ||
| High-molecular-weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: a prospective investigation. | Q35669151 | ||
| C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization | Q35765654 | ||
| Chronic critical limb ischemia | Q35807304 | ||
| Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. | Q35852788 | ||
| Abnormal myofiber morphology and limb dysfunction in claudication | Q35882665 | ||
| Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus | Q35894298 | ||
| Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial. | Q36014060 | ||
| Marriage of resistance and conduit arteries breeds critical limb ischemia | Q36038073 | ||
| An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease | Q36146980 | ||
| Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery | Q36369429 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peripheral artery disease | Q378681 |
| biomarker | Q864574 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 11294-11322 | |
| P577 | publication date | 2015-05-18 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | A review of the pathophysiology and potential biomarkers for peripheral artery disease | |
| P478 | volume | 16 |
| Q87815086 | 7(th) Asian PAD Workshop |
| Q92153753 | A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia |
| Q90192845 | Altered Metabolomic Profile in Patients with Peripheral Artery Disease |
| Q90640700 | Apolipoprotein E Gene Polymorphism, Glycated Hemoglobin, and Peripheral Arterial Disease Risk in Chinese Type 2 Diabetic Patients |
| Q36204177 | Association of peripheral arterial disease with all-cause and cardiovascular mortality in hemodialysis patients: a meta-analysis |
| Q47973482 | Carbon dioxide water-bath treatment augments peripheral blood flow through the development of angiogenesis |
| Q40114454 | Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes |
| Q64115626 | Cohort Study Examining the Association Between Blood Pressure and Cardiovascular Events in Patients With Peripheral Artery Disease |
| Q33885504 | Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease |
| Q89900560 | Development of a two-stage limb ischemia model to better simulate human peripheral artery disease |
| Q33757625 | Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials |
| Q38737905 | Epigenetics and Peripheral Artery Disease |
| Q91817237 | Gene-expression profiles of abdominal perivascular adipose tissue distinguish aortic occlusive from stenotic atherosclerotic lesions and denote different pathogenetic pathways |
| Q89014944 | High serum leptin level is associated with peripheral artery disease in adult peritoneal dialysis patients |
| Q36309576 | High serum resistin levels are associated with peripheral artery disease in the hypertensive patients |
| Q90115248 | Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia |
| Q93081232 | Oxidative Stress in Peripheral Arterial Disease (PAD) Mechanism and Biomarkers |
| Q55005264 | Oxidative stress and antioxidant treatment in patients with peripheral artery disease. |
| Q33599707 | Peripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspects |
| Q58796981 | Plasma Heme Oxygenase-1 Levels in Patients with Coronary and Peripheral Artery Diseases |
| Q98177752 | Potential Fast COVID-19 Containment With Trehalose |
| Q92589761 | RhoGTPase in Vascular Disease |
| Q40724074 | Serum carboxy-terminal telopeptide of type I collagen (I-CTP) is predictive of clinical outcome in peripheral artery disease patients following endovascular therapy |
| Q41317574 | Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects. |
| Q46085332 | The Need for Translational Research to Advance Peripheral Artery Disease Management. |
| Q88648379 | Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study |
| Q98906806 | VEGF-A splice variants bind VEGFRs with differential affinities |
Search more.